漏 HUG. Pre Laura Rubbia-Brandt & Pre Caroline Samer
Laura Rubbia-Brandt, Full Professor in the Department of Pathology and Immunology at UNIGE Faculty of Medicine, Head of the and of the at the HUG, has been elected an honorary member for her outstanding services to the promotion of science, to the healthcare system and/or to the SAMS. Caroline Samer, Associate Professor and Director of the Department of Anaesthesiology, Pharmacology, Intensive Care and Emergency Medicine at the UNIGE Faculty of Medicine and Head of the at the HUG, has been elected an individual member in recognition of her scientific excellence. They are among the 9 new members - eight of them women - elected to the Senate of the , its supreme body.
Laura Rubbia-Brandt
After a medical training in Geneva, she specialised in clinical pathology at the HUG and the Hôpital Beaujon in Paris. She has been a full professor at the Faculty of Medicine and Head of Clinical Pathology at the HUG since 2007, and has headed the Diagnostic Department since its creation in 2019.
She makes a leading contribution to innovation in medicine, particularly in the deployment of digital pathology and computational pathology, and in the implementation of AI in clinical pathology. Her research interests include the pathogenesis of chemotherapy-associated liver injury, vascular liver injury and colorectal metastasis. She also teaches gastrointestinal and liver pathology at the Faculty of Medicine.
A nationally and internationally recognised expert, she has chaired the Swiss Hepatobiliary Pathology Group and the Swiss Pathology Society. An active member of the Board of Directors of the Swiss Association for the Study of the Liver, she is the lead pathologist for the Swiss Hepatitis C Cohort Study Group, and a member of the Gastrointestinal Pathology Group of the Swiss Institute for Applied Cancer Research. She is also a member of the United States and Canadian Academy of Pathology (USCAP), the Hans Pooper Society of Liver Pathology, the Laennec International Liver Pathology Expert Group and the International Academy of Pathology (IAP).
Caroline Samer
After her medical traning in Geneva, she specialised in internal medicine and clinical pharmacology and toxicology. She then completed a PhD in pharmacogenomics, followed by a post-doctoral fellowship in molecular pharmacology in Sydney. In 2019, she took charge of the Pharmacogenomics and Personalised Therapy Unit at the HUG, and in 2022 became Head of the Division of Clinical Pharmacology and Toxicology. Appointed assistant professor at the Faculty of Medicine in 2020, then associate professor in 2022, she became Director of the academic Department of Anaesthesiology, Pharmacology, Intensive Care and Emergency Medicine in 2024. She is also a delegate of the Dean's Office in charge of data.
Her research focuses on personalising drug therapy and making it safer (precision medicine approach) by measuring gene-environment-disease interactions at pharmacokinetic level and exploiting advances in various biomic technologies, particularly pharmacogenomics. She is president of the Swiss Society of Clinical Pharmacology and Toxicology (SSPTC) and of the Swiss Society of Pharmacology and Toxicology (SSPT), vice-president of the Research Ethics Committee of the Canton of Geneva (CCER), president-elect of the International Union for Basic and Clinical Pharmacology (IUPHAR) and a member of the Executive Committee of the Council for International Organizations of Medical Sciences (CIOMS).